According to the manufacturer, what is maximum time allowed between preparation and administration for a multi-dose reconstituted product?

An 18-hour interval between reconstitution and use exceeds the manufacturer's recommended timeframe for the Shingrix vaccine. Extended storage beyond the specified 6-hour limit may compromise the vaccine's quality, potentially reducing its efficacy and putting patient health at risk.

Allowing a full week to elapse between reconstitution and administration significantly surpasses the manufacturer's guidelines for the Shingrix vaccine. Such a prolonged delay can introduce uncertainties regarding the vaccine's stability and potency, leading to potential inefficacy and decreased protection against shingles.

Waiting 14 days before using the reconstituted Shingrix vaccine far exceeds the recommended time frame provided by the manufacturer. Extended storage for such a prolonged period may result in significant degradation of the vaccine components, compromising its efficacy and rendering it potentially unsafe for patient use.